ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Japan Delegation Visits Wisconsin to Explore Strength in Biohealth Innovation

A high-level Japanese delegation focused on biohealth will visit two cities in Wisconsin, Madison and Milwaukee (November 5-7), strengthening ties between Japanese and U.S. leaders in the rapidly advancing field of biohealth. The delegation is comprised of 23 delegates from 19 Japanese companies and representing the following industries: trading company, banking institutions, R&D, medical device manufacturer, CDMO, and healthcare-related startups.

The delegation, organized by the Japan External Trade Organization (JETRO), Wisconsin Economic Development Corporation (WEDC), and the Japan America Society of Wisconsin (JASWI) will feature visits to key sites in the state’s biohealth ecosystem.

The U.S. bio-healthcare market is expected to grow to $2 trillion by 2034, about three times the current size, expanding to a diverse range of industries such as medical, agriculture and food, environment and energy, chemicals, and IT and data. In addition to existing locations such as Boston and the Research Triangle, Wisconsin has rapidly gained traction as a new biotech hub in recent years.

In 2023, Wisconsin was selected as a "Regional Technology and Innovation Hub" by the U.S. Economic Development Agency (EDA), leveraging approximately $49 million in federal funding to advance industry-academia-government collaboration centered on the Wisconsin Biohealth Tech Hub. With the University of Wisconsin, GE HealthCare, Exact Sciences, and others at its core, next-generation medicine and life sciences research are accelerating. In addition, the presence of Japanese companies is increasing, such as Fujifilm's large-scale investment in cell therapy production bases.

This mission will allow the delegates to experience Wisconsin's strengths firsthand. A business matching and networking program with local universities, research institutes, and startup companies has also been arranged. This will be a valuable opportunity to deepen the understanding of the U.S. bio market and explore future collaborations and advancements.

To gain insight into the region's strength in the biohealth industry, the delegation will visit:

  • Exact Sciences Corporation (a leading company in molecular diagnostics)
  • Promega Corporation (a global company of reagents and instruments for life science research)
  • GE HealthCare (a global leader in diagnostic imaging and patient monitoring)
  • University of Wisconsin School of Medicine and Public Health (a leading life sciences research hub in the United States)
  • Medical College of Wisconsin (the largest private medical research institution in the state)

JETRO is looking to continue their relationship with the State of Wisconsin to build on the growing momentum between the region and Japan in the biohealth industry.

JETRO, together with Madison-based accelerator gener8tor, will host a pitch and networking reception on Thursday, November 6, from 4:00 PM to 7:00 PM. For more details and registration, please visit: https://www.jetro.go.jp/usa/topics/wisconsin-j-bridge-event-2025.html

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.56
+0.02 (0.01%)
AAPL  274.61
+0.50 (0.18%)
AMD  209.17
+1.59 (0.77%)
BAC  54.81
-0.52 (-0.94%)
GOOG  307.73
-1.59 (-0.51%)
META  657.15
+9.64 (1.49%)
MSFT  476.39
+1.57 (0.33%)
NVDA  177.72
+1.43 (0.81%)
ORCL  188.65
+3.73 (2.02%)
TSLA  489.88
+14.57 (3.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.